Reagent
Recombinant Mouse VEGF,CYT-Q00731
Click£º5258 Release date£º2020-5-13 Author£ºAdministrator Source£ºOriginal
Recombinant Mouse VEGF,CYT-Q00731
Function
N-VEGF
Participates in the induction of key genes involved in the response to hypoxia and in the induction of angiogenesis such as HIF1A (PubMed:35455969).
Involved in protecting cells from hypoxia-mediated cell death (PubMed:35455969).1 Publication
Involved in protecting cells from hypoxia-mediated cell death (PubMed:35455969).1 Publication
VEGFA
Growth factor active in angiogenesis, vasculogenesis and endothelial cell growth. Induces endothelial cell proliferation, promotes cell migration, inhibits apoptosis and induces permeabilization of blood vessels. Binds to the FLT1/VEGFR1 and KDR/VEGFR2 receptors, heparan sulfate and heparin. Binds to the NRP1/neuropilin-1 receptor. Binding to NRP1 receptor initiates a signaling pathway needed for motor neuron axon guidance and cell body migration, including for the caudal migration of facial motor neurons from rhombomere 4 to rhombomere 6 during embryonic development (PubMed:26503042).
Also binds the DEAR/FBXW7-AS1 receptor (PubMed:16293765).
May play a role in increasing vascular permeability during lactation, when increased transport of molecules from the blood is required for efficient milk protein synthesis (By similarity).By Similarity
2 Publications
Also binds the DEAR/FBXW7-AS1 receptor (PubMed:16293765).
May play a role in increasing vascular permeability during lactation, when increased transport of molecules from the blood is required for efficient milk protein synthesis (By similarity).By Similarity
|
Order Information |
|||||
|
Cat./REF. |
Size |
Price($£© |
Price(€) |
Price(£¤/CNY£© |
Price(£¤/JYP£© |
|
CYT-Q00731 |
5ug |
$75.00 |
€ 90.00 |
£¤750.00 |
£¤14,925.00 |
|
CYT-Q00731 |
20ug |
$209.00 |
€ 250.80 |
£¤2,090.00 |
£¤41,591.00 |
|
CYT-Q00731 |
100ug |
$836.00 |
€ 1,003.20 |
£¤8,360.00 |
£¤166,364.00 |
On an article£ºRecombinant Mouse M-CSF,CYT-P07141
Next article£ºRecombinant Rat SDC4,CYT-P34901
